Business Description
MegaPro Biomedical Co Ltd
ISIN : TW0006827009
Description
MegaPro Biomedical Co Ltd is a nanomedicine development company.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.3 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 28.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 10.6 | |||||
| 3-Year EPS without NRI Growth Rate | 7.5 | |||||
| 3-Year FCF Growth Rate | 16.2 | |||||
| 3-Year Book Growth Rate | -0.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.1 | |||||
| 9-Day RSI | 30.24 | |||||
| 14-Day RSI | 35.08 | |||||
| 6-1 Month Momentum % | -6.53 | |||||
| 12-1 Month Momentum % | -6.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.77 | |||||
| Quick Ratio | 10.77 | |||||
| Cash Ratio | 6.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | 0.19 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -780483.33 | |||||
| Net Margin % | -708600 | |||||
| FCF Margin % | -578255.56 | |||||
| ROE % | -45.23 | |||||
| ROA % | -41.38 | |||||
| ROIC % | -73.73 | |||||
| ROC (Joel Greenblatt) % | -86.97 | |||||
| ROCE % | -43.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.91 | |||||
| Price-to-Tangible-Book | 5.19 | |||||
| EV-to-EBIT | -9.45 | |||||
| EV-to-EBITDA | -10.87 | |||||
| EV-to-Revenue | 66810.78 | |||||
| EV-to-FCF | -11.55 | |||||
| Price-to-Net-Current-Asset-Value | 7.14 | |||||
| Price-to-Net-Cash | 12.99 | |||||
| Earnings Yield (Greenblatt) % | -10.58 | |||||
| FCF Yield % | -7.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MegaPro Biomedical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 0.018 | ||
| EPS (TTM) (NT$) | -2.3 | ||
| Beta | 0 | ||
| Volatility % | 31.11 | ||
| 14-Day RSI | 35.08 | ||
| 14-Day ATR (NT$) | 0.724023 | ||
| 20-Day SMA (NT$) | 23.9 | ||
| 12-1 Month Momentum % | -6.26 | ||
| 52-Week Range (NT$) | 20.4 - 33.094329 | ||
| Shares Outstanding (Mil) | 57.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MegaPro Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MegaPro Biomedical Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
MegaPro Biomedical Co Ltd Frequently Asked Questions
What is MegaPro Biomedical Co Ltd(ROCO:6827)'s stock price today?
The current price of ROCO:6827 is NT$23.00. The 52 week high of ROCO:6827 is NT$33.09 and 52 week low is NT$20.40.
When is next earnings date of MegaPro Biomedical Co Ltd(ROCO:6827)?
The next earnings date of MegaPro Biomedical Co Ltd(ROCO:6827) is .
Does MegaPro Biomedical Co Ltd(ROCO:6827) pay dividends? If so, how much?
MegaPro Biomedical Co Ltd(ROCO:6827) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers